Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

FTSE 100 heads for fourth session of gains

Published 10/24/2019, 03:18 PM
Updated 10/24/2019, 03:24 PM
FTSE 100 heads for fourth session of gains
UK100
-
NWG
-
AZN
-
FTMC
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 up 0.1%, FTSE 250 up 0.2%
* AstraZeneca biggest boost to main index
* RBS slides after reporting Q3 loss

Oct 24 (Reuters) - London's FTSE 100 held firm at a near
one-month high on Thursday as gains in AstraZeneca after a 2019
target upgrade countered losses in Royal Bank of Scotland
following a weak third-quarter update, while midcaps
outperformed as sterling rose.
The blue-chip index .FTSE inched up by 0.1% at 0708 GMT,
while the FTSE 250 index .FTMC gained 0.2%.
AstraZeneca AZN.L added 2.3% after the pharmaceutical
giant raised its annual product sales forecast for the second
time this year, thanks in part to strong demand for new cancer
treatments. On the other end of the spectrum was Royal Bank of Scotland
RBS.L that skidded 3% as it swung to a third-quarter loss due
to a fresh 900 million pound provision to settle mis-selling
claims in Britain's biggest consumer banking scandal.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.